Key result
Nonalcoholic fatty liver disease was significantly associated with the presence of coronary atherosclerotic plaques (OR 1.48) in asymptomatic adults without a history of cardiovascular disease.
Why the study?
Is nonalcoholic fatty liver disease associated with the presence and morphology of subclinical coronary atherosclerosis in asymptomatic subjects?
Cross-Sectional (n=772)
No
Is nonalcoholic fatty liver disease associated with the presence and morphology of subclinical coronary atherosclerosis in asymptomatic subjects?
Odds Ratio: 1.48 (95% CI 1.05–2.08)
Absolute Event Rate: 50% vs 33.6%
p-value: p=0.025
Nonalcoholic fatty liver disease is independently associated with the presence and calcified morphology of subclinical coronary atherosclerosis in asymptomatic individuals, highlighting its potential utility in cardiovascular risk stratification.
May inform subclinical CAD risk stratification in asymptomatic adults; leaves open need for prospective outcome trials.
PURPOSE: In this study, we aimed to evaluate whether nonalcoholic fatty liver disease (NAFLD) was associated with the presence and morphology of coronary atherosclerotic plaques shown by multidetector computed tomography (MDCT) in asymptomatic subjects without a history of cardiovascular disease. MATERIALS AND METHODS: We retrospectively enrolled 772 consecutive South Korean individuals who had undergone both dualsource 64-slice MDCT coronary angiography and hepatic ultrasonography during general routine health evaluations. The MDCT studies were assessed for the presence, morphology (calcified, mixed, and non-calcified), and severity of coronary plaques. RESULTS: Coronary atherosclerotic plaques were detected in 316 subjects (40.9%) by MDCT, and NAFLD was found in 346 subjects (44.8%) by hepatic ultrasonography. Subjects with NAFLD had higher prevalences of all types of atherosclerotic plaque and non-calcified, mixed, and calcified plaques than the subjects without NAFLD. However, the prevalence of significant stenosis did not differ between groups. After adjusting for age, smoking status, diabetes mellitus, hypertension, dyslipidemia, and metabolic syndrome, NAFLD remained a significant predictor for all types of coronary atherosclerotic plaque [odds ratio (OR): 1.48; 95% confidence interval (CI): 1.05-2.08; p=0.025] in binary logistic analysis, as well as for calcified plaques (OR: 1.70; 95% CI: 1.07-2.70; p=0.025) in multinomial regression analysis. CONCLUSION: Our study demonstrated that NAFLD was significantly associated with the presence and the calcified morphology of coronary atherosclerotic plaques detected by MDCT. Further prospective clinical studies are needed to clarify the exact physiopathologic role of NAFLD in coronary atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2015) conducted a cross-sectional in Asymptomatic subjects without a history of cardiovascular disease (n=772). Nonalcoholic fatty liver disease (NAFLD) vs. Subjects without NAFLD was evaluated on Presence of any type of coronary atherosclerotic plaque (OR 1.48, 95% CI 1.05-2.08, p=0.025). Nonalcoholic fatty liver disease was significantly associated with the presence of coronary atherosclerotic plaques (OR 1.48) in asymptomatic adults without a history of cardiovascular disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: